Condition
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 2 (3), Phase 3 (1), Phase 1 (1). The most active sponsors are Emory University (3), National Cancer Institute (NCI) (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1Country
Newest Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials
All recruiting trials (8)
-
Cemiplimab with or without CDX-1140 given before surgery for stage III-IV head and neck cancer
This trial tests whether adding the immune stimulant CDX-1140 to cemiplimab before surgery helps shrink tumors in people with resectable stage III-IV head and neck squamous cell carcinoma.
-
Autologous tumor membrane vesicle (TMV) vaccine alone or with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
This trial tests whether a vaccine made from a patient's own tumor (TMV), given alone or with pembrolizumab, can help people with recurrent or metastatic head and neck squamous cell carcinoma who had tumor tissue banked at surgery.
-
Remote hearing tests for patients with head and neck cancer receiving chemotherapy or radiation
This study is testing if remote hearing tests can help patients with advanced head and neck cancer keep track of their hearing loss during chemotherapy or radiation, making it easier for those who live far away to participate.
-
Combining lovastatin and pembrolizumab for advanced head and neck cancer treatment
This study is testing if combining a cholesterol-lowering drug called lovastatin with an immunotherapy drug called pembrolizumab can help people with advanced head and neck cancer feel better and live longer.
-
Combining cetuximab with pembrolizumab for advanced head and neck cancer
This study is testing if adding cetuximab to pembrolizumab can help people with advanced head and neck cancer live longer and feel better compared to just using pembrolizumab alone.
-
Identifying biomarkers for HPV-related oropharyngeal cancer
This study is trying to find specific markers in blood and saliva that can help identify HPV-related throat cancer in patients who are already diagnosed with advanced stages of the disease.
-
Combining cabozantinib and nivolumab to treat advanced melanoma and head and neck cancer
This study is testing a combination of two cancer drugs, cabozantinib and nivolumab, to see if they can help people with advanced melanoma or head and neck cancer while also looking at how to better match treatments to patients based on their tumor characteristics.
-
Studying how well head and neck cancer patients follow swallowing exercises after radiation
This study looks at how well people with head and neck cancer stick to their swallowing exercises after radiation treatment and what factors might help or hinder them.
Related topics
Quick answers
How many Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.